ANXA5 and cholangiocarcinoma: Flow cytometry analysis showed that PA-CM dramatically decreased the percentages of viable CCA cells (annexin V−/PI−) and increased the percentages of apoptotic CCA cells, which included both early (annexin V+/PI−) and late (annexin V+/PI+) stages of apoptosis, compared to controls, in a dose- and time-dependent manner.